IMMUNOVIA AB financial statements, including revenue, expenses, profit, and loss

The total revenue of IMMNOV for the last quarter is 156.00 k SEK, and it's 0.65% higher compared to the previous quarter. The net income of Q1 24 is -2.95 M SEK.